Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder

NCT05336188 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT05336188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05336188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
Lead sponsor
University of Arkansas
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
May 16, 2023
Completion date
September 30, 2028
Enrollment
336 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attentional bias, craving, ecological momentary assessment, magnetic resonance imaging, mobile applications, opiate substitution treatment, opioid-related disorders